DGP IgG

Celiac disease is common and often goes undiagnosed for years. Part of the reason is that the usual first-line blood test does not catch everyone, particularly people whose immune systems make little of one key antibody.

This marker helps fill that gap. It can flag a gluten-driven immune reaction that a standard celiac panel sometimes reports as clear, which matters because untreated celiac disease keeps inflaming and flattening the lining of your small intestine.

What This Antibody Actually Measures

When you eat gluten, an enzyme in your intestinal lining chemically alters gliadin, one of gluten's main proteins. This altered version is far more likely to provoke the immune system. DGP IgG (deamidated gliadin peptide immunoglobulin G) is the antibody your body builds against that altered fragment.

A high level signals that your immune system has mounted a specific, gluten-directed response, the same process that drives the gut damage of celiac disease. A low or negative result means little or no current gluten-directed IgG reaction, though on its own it does not fully rule celiac disease out.

Detecting Celiac Disease

For diagnosing celiac disease, this antibody performs reasonably well. In one meta-analysis of children under two years old, it correctly flagged about 96 out of 100 confirmed cases and correctly cleared about 96 out of 100 people without the disease. Broader reviews, though, put its overall accuracy somewhat lower, catching roughly 88 out of 100 cases, and find the standard tTG-IgA test performs at least as well in this age group. In adults with a high suspicion of celiac disease going to biopsy, one study found it caught roughly 97 out of 100 cases while producing essentially no false positives, a figure inflated by that high-suspicion population.

Its accuracy is close to, though modestly below, the more commonly ordered celiac test, tissue transglutaminase IgA (tTG-IgA). The value here is not that it replaces that test, but that it detects a slightly different slice of disease and holds up in situations where the standard test fails.

When the Standard Test Falls Short

The usual celiac screen measures an IgA-class antibody. Some people naturally make very little IgA (a condition called selective IgA deficiency), and in them that test reads falsely negative no matter how active their celiac disease is. Because this marker is an IgG-class antibody, it still works. In a study of 941 people, the IgG deamidated gliadin test and an IgG version of the standard test showed similar ability to catch celiac disease in IgA-deficient individuals.

Very young children have sometimes been the other blind spot. Some toddlers with biopsy-confirmed celiac disease have been reported negative on tTG-IgA but positive on this marker. Older guidelines suggested pairing the two tests in children under two, but the 2023 American College of Gastroenterology update now recommends tTG-IgA as the preferred single test even in this age group unless the child is IgA-deficient. This marker still has a role when suspicion stays high despite a negative standard result or when IgA is low.

An Early Warning in At-Risk Children

In children genetically prone to celiac disease, this antibody can be the first sign that gluten tolerance is breaking down. In a prospective cohort of 325 at-risk children, a rise in this marker preceded the standard antibody's appearance and clinical diagnosis by 6 to 12 months in about 74% of those who went on to develop the disease.

One caveat keeps this in perspective. An early rise in this antibody alone, without the standard celiac antibody also turning positive, is not by itself proof that celiac disease will develop. It is an early risk signal that warrants closer follow-up, not an immediate diagnosis.

Tracking Gluten Exposure and Healing

In people already diagnosed, this antibody tends to fall on a gluten-free diet and correlates with the state of the intestinal lining, making it useful for follow-up. In a cohort of 100 treated patients, deamidated gliadin antibodies tracked closely with the flattening of the intestinal surface (villous atrophy).

It is a helpful but imperfect adherence check. In a study of treated patients, those with objective gluten exposure detected in stool were far more likely to be antibody-positive, yet most people with low-level exposure still tested negative on serology. A normal result does not guarantee a perfectly clean diet or a fully healed gut.

Why One Reading Is Not Enough

This antibody moves with what you eat and how active your disease is, so a single number is a snapshot, not the full story. A rising trend can precede a positive standard test by months, and a falling trend after cutting gluten is one of the clearest signs that removing the trigger is working.

If you are being evaluated, get a baseline while still eating gluten. If you start a gluten-free diet, retest in 3 to 6 months to confirm the level is dropping, then at least annually to catch hidden gluten exposure. Because different labs use different assays and cutoffs, compare results measured the same way whenever possible.

Making Sense of an Unexpected Result

A positive result is a starting point, not a verdict. Pair it with the standard celiac antibody (tTG-IgA) plus a total IgA level to check for IgA deficiency. When both this marker and the standard test are clearly positive in someone with symptoms, the probability of celiac disease is very high; when they disagree, the picture needs more work.

An isolated positive on this marker, especially at a low level or in someone with no symptoms, should be interpreted cautiously. Next steps often include HLA-DQ2/DQ8 genotyping (which can help exclude celiac disease when negative) and a referral to a gastroenterologist for a small-intestine biopsy, still the reference standard for confirming the diagnosis. Do not commit to a lifelong gluten-free diet based on a single borderline antibody alone.

When Results Can Be Misleading

The most important pitfall is diet. These antibodies form in response to gluten, so if you have already cut gluten out, the level can fade and produce a falsely reassuring negative. You must be eating gluten regularly for the test to be meaningful.

• Going gluten-free before testing: removing the trigger lowers the antibody and can mask real disease, the single most common cause of a falsely negative result.
• Assay differences: different labs use different kits and cutoffs, so numbers are not directly comparable across labs, and an unexpected result is worth repeating on the same platform.
• Isolated positivity in low-risk settings: a positive marker without symptoms or a positive standard test can be a false alarm, particularly at low levels.